Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation

Transplant Proc. 1995 Apr;27(2):1862-7.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alanine Transaminase / blood
  • Alprostadil / therapeutic use*
  • Aspartate Aminotransferases / blood
  • Blood Transfusion
  • Female
  • Graft Rejection / epidemiology
  • Graft Survival / drug effects*
  • Humans
  • Immunosuppression Therapy / methods
  • Liver Transplantation / immunology
  • Liver Transplantation / mortality
  • Liver Transplantation / physiology*
  • Male
  • Middle Aged
  • Organ Preservation
  • Prothrombin Time
  • Survival Rate
  • Time Factors
  • Treatment Failure

Substances

  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Alprostadil